Moneycontrol PRO
HomeNewsBusinessCoronavirus pandemic | Aligarh lab wrongly declares 68-year-old man COVID-19 positive

Coronavirus pandemic | Aligarh lab wrongly declares 68-year-old man COVID-19 positive

Officials said the test was conducted at a primary health centre (PHC) in Amroha after the man from Nauganva village complained of cold and sore throat

April 17, 2020 / 12:00 IST

A 68-year-old man from Uttar Pradesh’s Amroha was wrongly declared COVID-19 positive by an Aligarh lab. The incorrect test results, which was conducted for cold and sore throat, was reportedly because of a typographical error.

Officials said the test was conducted at a primary health centre (PHC) in Amroha after the elderly man from Nauganva village complained of cold and sore throat, reported Hindustan Times. The PHC’s in-charge, Dr Umar Farooq, said the man also had fever and was referred to Moradabad district hospital where he was admitted on April 6.

Farooq said the patient’s blood sample was sent for testing to a lab at Aligarh Medical College where samples for coronavirus were being tested. “When the test report came in, we were told by medical officials in Moradabad that the man had tested positive,” he said.

Six ambulances were immediately rushed to quarantine eight of his family members and track down others who had come into his contact. After conducting the screen test, all eight family members were tested negative.

However, in a twist of events, the Chief Medical Officer’s (CMO) office in Moradabad confirmed that the man’s name had been wrongly added to the list of positive cases. “The earlier report had, by mistake, mentioned that the patient was coronavirus positive,” said CMO Moradabad Dr M C Garg. The error was due to the misprint by the lab in Aligarh where the blood sample of the man was sent.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Megh Singh, CMO, Amroha, said the man was confirmed negative for coronavirus and discharged earlier this week. 

Moneycontrol News
first published: Apr 17, 2020 12:00 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347